BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25102893)

  • 1. Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis.
    Tan J; Maari C; Nigen S; Bolduc C; Bissonnette R
    J Dermatolog Treat; 2015; 26(4):373-5. PubMed ID: 25102893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
    Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
    Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
    Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
    Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.
    Halioua B; Paul C; Berbis P; Cambazard F; Doutre MS; Joly P; Richard MA; Aubin C; Gruber A; Chosidow O
    Eur J Dermatol; 2019 Feb; 29(1):59-66. PubMed ID: 30827949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema.
    Ferrucci S; Persichini P; Gola M; Scandagli I; Pigatto P; Legori A; Musumeci ML; Micali G; D'Agata E; Schena D; Azzolini A; Gallo R; Trave I; Cristaudo A; Patruno C; Napolitano M; Zucca M; Piras V; Stingeni L; Bianchi L; Corazza M; Zedde P; Foti C; Romita P; Cannavò SP; Guarneri F
    Dermatol Ther; 2021 May; 34(3):e14911. PubMed ID: 33619833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate versus Acitretin in the Treatment of Chronic Hand Dermatitis.
    O'Shea PM; Lugo-Somolinos A
    J Drugs Dermatol; 2015 Dec; 14(12):1389-91. PubMed ID: 26659930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
    Gola M; Milanesi N; D'Erme AM
    G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of chronic hand dermatitis with 36 continuous months of alitretinoin administration: report of three cases.
    Gulliver WP; Baker KA
    J Cutan Med Surg; 2012; 16(4):267-71. PubMed ID: 22784520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.
    Thaçi D; Augustin M; Westermayer B; Kamps A; Hennig M
    J Dermatolog Treat; 2016 Nov; 27(6):577-583. PubMed ID: 27618281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
    Lee JH; Youn JI; Kim TY; Choi JH; Park CJ; Choe YB; Song HJ; Kim NI; Kim KJ; Lee JH; Yoo HJ
    BMC Dermatol; 2016 Jul; 16(1):11. PubMed ID: 27455955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.
    Cheon DU; Kim JE; Ko JY; Ro YS
    J Dermatol; 2019 Nov; 46(11):998-1005. PubMed ID: 31535403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
    Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
    Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
    Oosterhaven JAF; Schuttelaar MLA
    BMJ Open; 2018 Jul; 8(7):e020192. PubMed ID: 29997136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry.
    Apfelbacher CJ; Ofenloch RF; Weisshaar E; Molin S; Bauer A; Mahler V; Heinrich A; von Kiedrowski R; Schmitt J; Elsner P; Diepgen TL
    Contact Dermatitis; 2019 Jan; 80(1):45-53. PubMed ID: 30246346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
    Augustin M; Thaçi D; Kamps A
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in the treatment of eczemas.
    Gola M; Carpentieri A; Loconsole F
    G Ital Dermatol Venereol; 2017 Dec; 152(6):560-564. PubMed ID: 29050445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.